Table 1

Clinical pathological characteristics of patients with NSCLC included in Sets 1–5

Patient demographicsSet 1Set 222Set 323Set 4Set 5
Number of samples3358473223
 Age (average and range)71 (51–90)69 (48–90)66 (48–85)66 (37–86)66 (49–80)*
Sex N (%)
 Male12 (36.4)29 (50)36 (76.6)15 (46.9)19 (82.6)
 Female21 (63.6)29 (50)11 (23.4)17 (53.1)4 (17.4)
Histology N (%)
 Adenocarcinoma32 (97)58 (100)27 (57.4)15 (46.9)17 (74)
 Squamous carcinomas20 (42.6)8 (25)6 (26)
 Carcinomas NOS6 (18.8)
 Carcinomas with neuroendocrine features1 (3)2 (6.3)
 Unknown1 (3)
Stage
 I7 (21.2)34 (58.6)6 (26.1)
 II16 (48.5)11 (19)3 (13)
 III3 (9.1)12 (20.7)3 (13)
 IV7 (21.2)1 (1.7)32 (100)11 (47.9)
KRAS status
 Mutant18 (54.5)34 (58.6)4 (17.4)
 Wild-type15 (45.5)24 (41.4)15 (65.2)
 Unknown47 (100)32 (100)4 (17.4)
  • * age is missing for two patients.

  • KRAS, Kirsten rat sarcoma viral oncogene homolog; NOS, Not otherwise specified; NSCLC, Non-Small Cell Lung Cancer.